This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Trinity Biotech's Stock Rises After Acquisition of Metabolomics
by Zacks Equity Research
TRIB acquires Metabolomics Diagnostics, expanding its platform with cutting-edge tech to enhance diagnostics in maternal health and diabetes management.
Universal Health Services, Inc. (UHS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic
by Zacks Equity Research
AXNX stock continues to gain following a favorable court ruling last week in a patent litigation with Medtronic.
These Hospital Stocks Are Trouncing the S&P 500 This Year
by Bryan Hayes
The Zacks Rank has consistently identified big winners, regardless of which pocket of the market they may reside.
Cardinal Health Stock Likely to Gain From the Acquisition of ION
by Zacks Equity Research
CAH is set to acquire Oncology Network for $1.115 billion, expanding its oncology offerings while supporting community-based cancer care across 10 states.
ITGR Shares May Gain on the Completion of Irish Facility Expansions
by Zacks Equity Research
Integer Holdings announces the completion of its Irish facility expansions in Galway and New Ross to support growth.
Zacks.com featured highlights include Universal Health Services, Carriage Services, AXIS Capital and EnerSys
by Zacks Equity Research
Universal Health Services, Carriage Services, AXIS Capital and EnerSys are part of the Zacks Screen of the Week article.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
4 Top Stocks to Buy for Value Investing After Fed Rate Cut
by Sumit Singh
Value investing is essentially about selecting stocks that are cheap but fundamentally sound. UHS, CSV, AXS & ENS boast a low P/CF ratio.
Stryker Shares May Gain on the Completion of the Acquisition of NICO
by Zacks Equity Research
SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.
ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe
by Zacks Equity Research
AngioDynamics' RECOVER-AV trial evaluates the AlphaVac F1885 System's safety and efficacy in treating acute pulmonary embolism in Europe.
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
by Zacks Equity Research
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
SNN Stock Rises on the Completion of First Case With CATALYSTEM System
by Zacks Equity Research
Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.
GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch
by Zacks Equity Research
GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.
Should Value Investors Buy Universal Health Services (UHS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
by Debasmita Chatterjee
UHS witnesses revenue growth from increased patient volumes and strategic initiatives. An extensive treatment network remains an added strength.
Here's Why You Should Retain McKesson Stock in Your Portfolio Now
by Zacks Equity Research
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
by Zacks Equity Research
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics
by Zacks Equity Research
BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.
Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?
by Zacks Equity Research
SEM's profitability is being impacted by rising costs and expenses.
Here's Why Universal Health Services (UHS) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include Century Communities, Powell Industries, Sylvamo, IAMGOLD and Universal Health Services
by Zacks Equity Research
Century Communities, Powell Industries, Sylvamo, IAMGOLD and Universal Health Services have been highlighted in this Screen of The Week article.
Teladoc Stock Rises 12% as Jefferies Boosts Price Target on BetterHelp
by Zacks Equity Research
TDOC's stock benefits from improving web traffic in its BetterHelp platform.
Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results
by Zacks Equity Research
MMSI announces 6-month results from its WRAPSODY WAVE trial, showing superior efficacy in extending AV fistula patency for dialysis patients.